These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16355368)

  • 1. Following a crush and a kiss: why is it lonely out there?
    Seth A
    Catheter Cardiovasc Interv; 2006 Jan; 67(1):56-7. PubMed ID: 16355368
    [No Abstract]   [Full Text] [Related]  

  • 2. Bifurcational lesions and the "crush" technique: understanding why it works and why it doesn't-a kiss is not just a kiss.
    Colombo A
    Catheter Cardiovasc Interv; 2004 Nov; 63(3):337-8. PubMed ID: 15505834
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioabsorbable coronary stents.
    Lobodzinski SS
    Cardiol J; 2008; 15(6):569-71. PubMed ID: 19039765
    [No Abstract]   [Full Text] [Related]  

  • 4. Biodegradable stents.
    Ramcharitar S; Serruys PW
    Minerva Cardioangiol; 2008 Apr; 56(2):205-13. PubMed ID: 18319699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifurcational lesions: searching the solution.
    Colombo A
    Catheter Cardiovasc Interv; 2005 May; 65(1):17-8. PubMed ID: 15822073
    [No Abstract]   [Full Text] [Related]  

  • 6. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results.
    Mixon T; Fitzsimmons P
    J Invasive Cardiol; 2006 Jun; 18(6):E166-8. PubMed ID: 16775892
    [No Abstract]   [Full Text] [Related]  

  • 7. Bifurcation intervention: is it crush time yet?
    Williams DO; Abbott JD
    J Am Coll Cardiol; 2005 Aug; 46(4):621-4. PubMed ID: 16098425
    [No Abstract]   [Full Text] [Related]  

  • 8. Percutaneous treatment of coronary bifurcation lesions: a novel "extended Y" technique with complete lesion stent coverage.
    Helqvist S; Jørgensen E; Kelbaek H; Aljabbari S; Thuesen L; Flensted Lassen J; Saunamäki K
    Heart; 2006 Jul; 92(7):981-2. PubMed ID: 16775110
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".
    Galassi AR; Colombo A; Buchbinder M; Grasso C; Tomasello SD; Ussia GP; Tamburino C
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):976-83. PubMed ID: 17295334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term safety: not only a drug eluting stents issue.
    Fineschi M; Zacà V; Gori T
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):1051; author reply 1052. PubMed ID: 18044789
    [No Abstract]   [Full Text] [Related]  

  • 11. Applying drug-eluting stents in clinical practice.
    King SB
    Am J Cardiol; 2007 Sep; 100(5A):25K-31K. PubMed ID: 17719350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodynamics analysis of intravascular stents with different design features].
    Liang D; Yang D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Dec; 23(6):1241-4. PubMed ID: 17228717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifurcation stenting: current strategies and new devices.
    Latib A; Colombo A; Sangiorgi GM
    Heart; 2009 Mar; 95(6):495-504. PubMed ID: 18812408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
    Belardi J
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):599. PubMed ID: 18360848
    [No Abstract]   [Full Text] [Related]  

  • 17. Bare metal stents: no longer passé?
    Bavry AA; Bhatt DL
    J Invasive Cardiol; 2006 Sep; 18(9):403-4. PubMed ID: 16954576
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents.
    Gagnor A; Varbella F; Rubartelli P; Luceri S; Conte MR
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):201-4. PubMed ID: 18192816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restenosis related to percutaneous coronary intervention has been solved?
    Kivelä A; Hartikainen J
    Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards defining the role of drug eluting stents.
    Tarantini G; Ramondo A; Razzolini R
    Minerva Cardioangiol; 2008 Feb; 56(1):29-34. PubMed ID: 18432166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.